SCHEMBL25663239

SCHEMBL25663239

c1ccc2c(c1)ccc1cc(-c3ccc(N(c4ccc(-c5ccc6c(ccc7ccccc76)c5)cc4)c4ccc(-c5cc6sc7ccccc7c6cn5)cc4)cc3)ccc12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDO1 P14902 3/20 0.35
▸ TDO2 P48775 3/20 0.35
▸ RAB9A P51151 3/20 0.34
▸ MAPT P10636 2/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ HPGD P15428 1/20 0.34
▸ GPR3 P46089 1/20 0.32
▸ NPC1 O15118 2/20 0.32
▸ LMNA P02545 1/20 0.32
▸ RECQL P46063 1/20 0.32
▸ CYP11B1 P15538 1/20 0.31
▸ HIF1A Q16665 1/20 0.30
▸ CYP1B1 Q16678 1/20 0.30
▸ HSD17B10 Q99714 1/20 0.30
▸ GABRP O00591 1/20 0.30
▸ GABRD O14764 1/20 0.30
▸ GABRA1 P14867 1/20 0.30
▸ GABRB1 P18505 1/20 0.30
▸ GABRG2 P18507 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26833747 0.93 IDO1 (0.34) IDO1TDO2RAB9AMAPTSMN1; SMN2
SCHEMBL25663240 0.93 ALDH1A1 (0.35) IDO1TDO2RAB9AMAPTSMN1; SMN2
SCHEMBL25663242 0.92 RAB9A (0.34) IDO1TDO2RAB9AMAPTSMN1; SMN2
SCHEMBL24055536 0.91 IDO1 (0.38) IDO1TDO2RAB9ASMN1; SMN2ALDH1A1
SCHEMBL25663233 0.91 ALDH1A1 (0.39) IDO1TDO2RAB9AMAPTSMN1; SMN2
SCHEMBL26834175 0.89 RAB9A (0.38) IDO1TDO2RAB9AMAPTSMN1; SMN2
SCHEMBL25663238 0.88 ALDH1A1 (0.37) IDO1TDO2RAB9AMAPTSMN1; SMN2
SCHEMBL24056062 0.87 ALDH1A1 (0.40) IDO1TDO2RAB9AMAPTSMN1; SMN2
SCHEMBL24055857 0.87 GPR3 (0.38) IDO1TDO2RAB9AMAPTSMN1; SMN2
SCHEMBL24056280 0.87 IDO1 (0.39) IDO1TDO2RAB9AMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2023-06-01 — — US disclosed
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2023-06-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE CHRM1, CHRM2, CHRM4 IDO1 623/4885TDO2 122/4885RAB9A 2198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback